newsfilter
← Latest News
GlobeNewswire·

Immix Biopharma to Present at the Stifel 2025 Healthcare Conference

Los Angeles, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and